EIF2A and prostate cancer: The phosphorylation of eIF2α was also robustly enhanced in the prostate cancer cell lines compared to GI tumor types, yet in contrast to prior work in other tumor cell types, the phosphorylation of PKR-like endoplasmic reticulum kinase (PERK) was not significantly elevated.